The FDA has approved the use of Thyrogen (thyrotropin alfa for injection) to be used in combination with radioiodine to ablate or destroy any remaining thyroid tissue in patients who have had ...

Thyrogen is used in the treatment and follow-up diagnosis of thyroid cancer. The FDA has developed a set of criteria to help healthcare professionals identify patients for whom ...

Thyrogen is currently available in more than 45 countries. It was first approved in the United States in 1998 for use in patients with well- differentiated thyroid cancer who have had their ...

The EU has approved a spinal implant system (Total Facet), a therapeutic indication for thyrotropin alfa injection (Thyrogen), a dual-chamber pacemaker (EnRhythm), and single- and dual-chamber ...

PROVIDENCE, R.I. – A two-week low-iodine diet is necessary for adequate outpatient preparation for 131-I thyrogen scanning in patients taking levothyroxine, according to a recent study sponsored ...

Among the 8 are Thyrogen. Among 8 drug shortages reported by the FDA on June 30 and July 1, 6 are injections, continuing at least part of the trend that most shortages involve generic injectables.

Fill/finish is the only part of Thyrogen production that takes place at Genzyme's Allston Landing site. The cancer treatment is manufactured at a plant in Framingham, MA, some 20 miles west of the ...

Supplies of Sanofi’s Thyrogen treatment will be in short supply until 2012, longer than originally expected, European authorities said. No new patients should be given the thyroid-stimulating ...

Genzyme <GENZ.O> has warned of a continued supply shortage of Thyrogen, a medicine used to treat patients that have had a thyriodectomy due to cancer, and its use should be restricted, Europe's ...